Japanese drugmaker Eisai and US-based Biogen have been working together on advancing research in the space of Alzheimer’s for nearly a decade. Finally, the FDA, granted the fruits of that labor, Leqembi, its blessing for intravenous use. This marks the first approved treatment that can slow the progression of Alzheimer’s.

  • @VoxelBase
    link
    English
    201 year ago

    So good to see some advancement with this! I’ve watched two family members wither away because of it.

    • @CaptainPicard
      link
      English
      81 year ago

      Currently doing that. It’s fucking brutal.

      • @VoxelBase
        link
        English
        21 year ago

        I’m so sorry to hear that, it fucking sucks. Cherish the moments that you have left.